Literature DB >> 33685518

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.

Bakani Mark Ncube1, Admire Dube1, Kim Ward2.   

Abstract

Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policies and regulatory systems, a lack of competent regulatory professionals in National Medicines Regulatory Authorities (NMRAs) and ineffective regional collaborations among NMRAs. In response to national regulatory challenges in Africa, a number of regional harmonisation efforts were introduced through the African Medicines Regulatory Harmonisation (AMRH) initiative to, among others, expedite market authorisation of medical products and to facilitate the alignment of national legislative frameworks with the AU Model Law on Medical Products Regulation. The goals of the model law include to increase collaboration across countries and to facilitate the overall regional harmonisation process. The AMRH initiative is proposed to serve as the foundation for the establishment of the African Medicines Agency (AMA). The AMA will, as one of its mandates, coordinate the regional harmonisation systems that are enabled by AU Model Law domestication and implementation. In this paper, we review the key entities involved in regional and continental harmonisation of medicines regulation, the milestones achieved in establishing the AMA as well as the implementation targets and anticipated challenges related to the AU Model Law domestication and the AMA's establishment. This review shows that implementation targets for the AU Model Law have not been fully met, and the AMA treaty has not been ratified by the minimum required number of countries for its establishment. In spite of the challenges, the AU Model Law and the AMA hold promise to address gaps and inconsistencies in national regulatory legislation as well as to ensure effective medicines regulation by galvanising technical support, regulatory expertise and resources at a continental level. Furthermore, this review provides recommendations for future research.

Entities:  

Keywords:  AU model law on medical products regulation; African Medicines Agency; African Medicines Regulatory Harmonisation Initiative; Medicines regulatory harmonisation; Pharmaceutical policy

Year:  2021        PMID: 33685518     DOI: 10.1186/s40545-020-00281-9

Source DB:  PubMed          Journal:  J Pharm Policy Pract        ISSN: 2052-3211


  3 in total

1.  Industrial perceptions of medicines regulatory harmonization in the East African Community.

Authors:  Live Storehagen Dansie; Walter Denis Odoch; Christine Årdal
Journal:  PLoS One       Date:  2019-06-19       Impact factor: 3.240

Review 2.  Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative.

Authors:  Tariro Sithole; Gugu Mahlangu; Sam Salek; Stuart Walker
Journal:  Ther Innov Regul Sci       Date:  2020-04-29       Impact factor: 1.778

3.  Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.

Authors:  Kirti Narsai; Abeda Williams; Aukje Kaija Mantel-Teeuwisse
Journal:  South Med Rev       Date:  2012-07-23
  3 in total
  7 in total

1.  How COVID spurred Africa to plot a vaccines revolution.

Authors:  Aisling Irwin
Journal:  Nature       Date:  2021-04-21       Impact factor: 49.962

2.  Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.

Authors:  Nancy Ngum; Jane Mashingia; Margareth Ndomondo-Sigonda; Stuart Walker; Sam Salek
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 3.  Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review.

Authors:  Vijay Kumar Chattu; Vishal B Dave; K Srikanth Reddy; Bawa Singh; Biniyam Sahiledengle; Demisu Zenbaba Heyi; Cornelius Nattey; Daniel Atlaw; Kioko Jackson; Ziad El-Khatib; Akram Ali Eltom
Journal:  Int J Environ Res Public Health       Date:  2021-11-09       Impact factor: 3.390

4.  Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa.

Authors:  Kawaldip Sehmi; Janet L Wale
Journal:  Front Med Technol       Date:  2022-02-24

5.  The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes.

Authors:  Solomon Owusu Sekyere; Ivana Škrnjug-Yudov; Alexander Pinz; Heidi Meyer; Christoph Conrad
Journal:  Front Med (Lausanne)       Date:  2022-03-02

6.  Falsified and substandard medicines trafficking: A wakeup call for the African continent.

Authors:  Yusuf Hassan Wada; Abdullahi Abdulrahman; Musabu Ibrahim Muhammad; Vivian Chiemerie Owanta; Pearl Udoka Chimelumeze; Garba M Khalid
Journal:  Public Health Pract (Oxf)       Date:  2022-02-26

7.  COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.

Authors:  Marguerite Massinga Loembé; John N Nkengasong
Journal:  Immunity       Date:  2021-07-13       Impact factor: 31.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.